Xueqing Tang

1.0k total citations
47 papers, 644 citations indexed

About

Xueqing Tang is a scholar working on Nephrology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Xueqing Tang has authored 47 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 8 papers in Molecular Biology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Xueqing Tang's work include Renal Diseases and Glomerulopathies (10 papers), Autoimmune Bullous Skin Diseases (6 papers) and Reservoir Engineering and Simulation Methods (6 papers). Xueqing Tang is often cited by papers focused on Renal Diseases and Glomerulopathies (10 papers), Autoimmune Bullous Skin Diseases (6 papers) and Reservoir Engineering and Simulation Methods (6 papers). Xueqing Tang collaborates with scholars based in China, Australia and United Kingdom. Xueqing Tang's co-authors include Xueqing Yu, Qinghua Liu, Huajun Liu, Wenbin Liu, Lin Yuan, Huijuan Zhang, Zhange Li, Yiru Wang, Xiaoyuan Wang and Haiyang Zhang and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xueqing Tang

43 papers receiving 634 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueqing Tang China 13 202 201 195 109 90 47 644
Hong Ren China 13 107 0.5× 224 1.1× 234 1.2× 56 0.5× 123 1.4× 37 692
Jeong Hae Kie South Korea 16 128 0.6× 240 1.2× 181 0.9× 155 1.4× 29 0.3× 56 788
Hagen Staude Germany 11 76 0.4× 183 0.9× 91 0.5× 36 0.3× 38 0.4× 16 408
Yueqiang Li China 18 61 0.3× 337 1.7× 162 0.8× 232 2.1× 18 0.2× 39 819
Samuel Mon-Wei Yu United States 15 49 0.2× 210 1.0× 357 1.8× 186 1.7× 97 1.1× 34 830
Koei Yamada Japan 10 35 0.2× 139 0.7× 168 0.9× 257 2.4× 38 0.4× 10 630
Le‐Ting Zhou China 17 41 0.2× 358 1.8× 546 2.8× 151 1.4× 193 2.1× 36 966
Denise D’Andrea United States 14 82 0.4× 71 0.4× 138 0.7× 141 1.3× 147 1.6× 29 862
Michiya Shinozaki Japan 11 180 0.9× 121 0.6× 140 0.7× 332 3.0× 26 0.3× 20 734
Sema Uysal Türkiye 15 44 0.2× 27 0.1× 78 0.4× 112 1.0× 60 0.7× 45 617

Countries citing papers authored by Xueqing Tang

Since Specialization
Citations

This map shows the geographic impact of Xueqing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueqing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueqing Tang more than expected).

Fields of papers citing papers by Xueqing Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueqing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueqing Tang. The network helps show where Xueqing Tang may publish in the future.

Co-authorship network of co-authors of Xueqing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Xueqing Tang. A scholar is included among the top collaborators of Xueqing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueqing Tang. Xueqing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yingyu, Chenyang Zhang, Xueqing Tang, et al.. (2025). Enhanced high-energy-density WO 3 -based electrochromic batteries via acid-modified graphite foil cathode. Nano Research. 18(12). 94907799–94907799.
2.
Tang, Xueqing, et al.. (2025). Edaravone targets PDGFRβ to attenuate VSMC phenotypic transition. Life Sciences. 370. 123568–123568.
3.
Chen, Yingyu, Zhen Wang, Bowen Fan, et al.. (2025). Temperature-tolerant electrochromic devices enabled by LiCl water-in-salt electrolyte with excellent performance. Chinese Chemical Letters. 37(4). 110824–110824. 1 indexed citations
4.
Tang, Xueqing, Yang Shi, Pingping Tang, et al.. (2024). Tetrahydroberberrubine exhibits preventive effect on obesity by activating PGC1α-mediated thermogenesis in white and brown adipose tissue. Biochemical Pharmacology. 226. 116381–116381. 2 indexed citations
5.
Zhang, Jing, Xueqing Tang, Jie Wei, et al.. (2023). Rainbow‐Colored Carbon Nanotubes via Rational Surface Engineering for Smart Visualized Sensors. Advanced Science. 10(29). e2303593–e2303593. 6 indexed citations
6.
Xu, Lubin, Xueqing Tang, Nuo Si, et al.. (2023). Genetic and clinical characterization of familial renal glucosuria. Clinical Kidney Journal. 17(2). sfad265–sfad265. 3 indexed citations
8.
Zhang, Ying, Ping Chen, Baobao Wang, et al.. (2023). Containing anti-PLA2R IgG antibody induces podocyte injury in idiopathic membranous nephropathy. Renal Failure. 45(2). 2271986–2271986. 1 indexed citations
9.
Fan, Yuhua, Yue Zhang, Wenfeng Liu, et al.. (2023). lncR-GAS5 upregulates the splicing factor SRSF10 to impair endothelial autophagy, leading to atherogenesis. Frontiers of Medicine. 17(2). 317–329. 12 indexed citations
10.
Tang, Xueqing, et al.. (2022). Prognostic significance of the extent of tubulointerstitial lesions in patients with IgA nephropathy. International Urology and Nephrology. 55(3). 671–677. 4 indexed citations
11.
Tang, Xueqing, Yue Zhang, Xin Liu, et al.. (2021). Aloe-emodin derivative produces anti-atherosclerosis effect by reinforcing AMBRA1-mediated endothelial autophagy. European Journal of Pharmacology. 916. 174641–174641. 12 indexed citations
12.
Li, Huimin, Xin Liu, Lei Wang, et al.. (2021). Kanglexin delays heart aging by promoting mitophagy. Acta Pharmacologica Sinica. 43(3). 613–623. 32 indexed citations
13.
Zhang, Ying, Yipeng Liu, Liming Liang, et al.. (2020). Effect of Glomerular Mannose-Binding Lectin Deposition on the Prognosis of Idiopathic Membranous Nephropathy. Kidney & Blood Pressure Research. 45(5). 713–726. 13 indexed citations
14.
Liu, Huajun, et al.. (2017). IL-6/STAT3/miR-34a protects against neonatal lung injury patients. Molecular Medicine Reports. 16(4). 4355–4361. 7 indexed citations
15.
Wen, Qiong, Rong Rong, Fengxian Huang, et al.. (2016). Vitamin D-Binding Protein Is a Potential Urinary Biomarker of Irbesartan Treatment Response in Patients with IgA Nephropathy. Genetic Testing and Molecular Biomarkers. 20(11). 666–673. 7 indexed citations
16.
Chen, Wenfang, Zhibin Li, Xueqing Tang, et al.. (2015). Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria. Archives of Medical Science. 2(2). 332–339. 2 indexed citations
17.
Wen, Qiong, Li Zhang, Haiping Mao, et al.. (2013). Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics. Biochemical and Biophysical Research Communications. 438(3). 473–478. 15 indexed citations
18.
Qin, Jing, Qiongqiong Yang, Xueqing Tang, et al.. (2012). Clinicopathologic features and treatment response in nephrotic IgA nephropathy with minimal change disease. Clinical Nephrology. 79(1). 37–44. 18 indexed citations
20.
Chen, Wei, Xueqing Tang, Qinghua Liu, et al.. (2010). Short-term Outcomes of Induction Therapy With Tacrolimus Versus Cyclophosphamide for Active Lupus Nephritis: A Multicenter Randomized Clinical Trial. American Journal of Kidney Diseases. 57(2). 235–244. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026